These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 30539697

  • 1. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
    Zheng R, Fang X, He L, Shao Y, Guo N, Wang L, Liu M, Li D, Geng H.
    Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
    [Abstract] [Full Text] [Related]

  • 2. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y, Zheng R, Xu G, Huang Y, Li Y, Li D, Geng H.
    Am J Physiol Renal Physiol; 2021 Mar 01; 320(3):F475-F484. PubMed ID: 33491567
    [Abstract] [Full Text] [Related]

  • 3. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
    Zheng R, Li Y, Wang L, Fang X, Zhang J, He L, Yang L, Li D, Geng H.
    Kidney Int; 2020 Oct 01; 98(4):947-957. PubMed ID: 32464217
    [Abstract] [Full Text] [Related]

  • 4. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.
    Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.
    Biochem Biophys Res Commun; 2019 Oct 01; 517(4):677-683. PubMed ID: 31402115
    [Abstract] [Full Text] [Related]

  • 5. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
    Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR.
    Nucleic Acid Ther; 2019 Apr 01; 29(2):104-113. PubMed ID: 30676254
    [Abstract] [Full Text] [Related]

  • 6.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Milliner DS, Harris PC, Sas DJ, Cogal AG, Lieske JC.
    ; 1993 Apr 01. PubMed ID: 20301460
    [Abstract] [Full Text] [Related]

  • 7. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
    Chen Z, Zhang D, Zheng R, Yang L, Huo Y, Zhang D, Fang X, Li Y, Xu G, Li D, Geng H.
    Kidney Int; 2024 Mar 01; 105(3):496-507. PubMed ID: 38142039
    [Abstract] [Full Text] [Related]

  • 8. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
    Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N.
    Transplantation; 2008 May 15; 85(9):1253-60. PubMed ID: 18475180
    [Abstract] [Full Text] [Related]

  • 9. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
    Salido EC, Li XM, Lu Y, Wang X, Santana A, Roy-Chowdhury N, Torres A, Shapiro LJ, Roy-Chowdhury J.
    Proc Natl Acad Sci U S A; 2006 Nov 28; 103(48):18249-54. PubMed ID: 17110443
    [Abstract] [Full Text] [Related]

  • 10. Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.
    Wannous H.
    Pediatr Nephrol; 2023 Aug 28; 38(8):2643-2648. PubMed ID: 36917293
    [Abstract] [Full Text] [Related]

  • 11. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
    M'dimegh S, Omezzine A, Hamida-Rebai MB, Aquaviva-Bourdain C, M'barek I, Sahtout W, Zellama D, Souche G, Achour A, Abroug S, Bouslama A.
    Transpl Immunol; 2016 Nov 28; 39():60-65. PubMed ID: 27568336
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
    Salido E, Rodriguez-Pena M, Santana A, Beattie SG, Petry H, Torres A.
    Mol Ther; 2011 May 28; 19(5):870-5. PubMed ID: 21119625
    [Abstract] [Full Text] [Related]

  • 13. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
    Kanoun H, Jarraya F, Maalej B, Lahiani A, Mahfoudh H, Makni F, Hachicha J, Fakhfakh F.
    BMC Nephrol; 2017 Oct 02; 18(1):303. PubMed ID: 28969594
    [Abstract] [Full Text] [Related]

  • 14. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS, Groothof JW, Wanders RJ, Waterham HR, Wijburg FR.
    Ned Tijdschr Geneeskd; 2006 Jul 29; 150(30):1669-72. PubMed ID: 16922352
    [Abstract] [Full Text] [Related]

  • 15. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.
    Zabaleta N, Barberia M, Martin-Higueras C, Zapata-Linares N, Betancor I, Rodriguez S, Martinez-Turrillas R, Torella L, Vales A, Olagüe C, Vilas-Zornoza A, Castro-Labrador L, Lara-Astiaso D, Prosper F, Salido E, Gonzalez-Aseguinolaza G, Rodriguez-Madoz JR.
    Nat Commun; 2018 Dec 21; 9(1):5454. PubMed ID: 30575740
    [Abstract] [Full Text] [Related]

  • 16. A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.
    Li X, Gu J, Yang Y, Li J, Li Y.
    Tohoku J Exp Med; 2018 Dec 21; 246(4):233-241. PubMed ID: 30541997
    [Abstract] [Full Text] [Related]

  • 17. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.
    Nagara M, Tiar A, Ben Halim N, Ben Rhouma F, Messaoud O, Bouyacoub Y, Kefi R, Hassayoun S, Zouari N, Ben Ammar MS, Abdelhak S, Chemli J.
    Gene; 2013 Sep 15; 527(1):316-20. PubMed ID: 23810941
    [Abstract] [Full Text] [Related]

  • 18. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymic phenotype, and disease severity.
    Hoppe B, Danpure CJ, Rumsby G, Fryer P, Jennings PR, Blau N, Schubiger G, Neuhaus T, Leumann E.
    Am J Kidney Dis; 1997 Jan 15; 29(1):36-44. PubMed ID: 9002528
    [Abstract] [Full Text] [Related]

  • 19. Multiplex gene editing reduces oxalate production in primary hyperoxaluria type 1.
    Zheng R, Zhang DX, Shao YJ, Fang XL, Yang L, Huo YN, Li DL, Geng HQ.
    Zool Res; 2023 Nov 18; 44(6):993-1002. PubMed ID: 37759334
    [Abstract] [Full Text] [Related]

  • 20. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.
    Soliman NA, Nabhan MM, Abdelrahman SM, Abdelaziz H, Helmy R, Ghanim K, Bazaraa HM, Badr AM, Tolba OA, Kotb MA, Eweeda KM, Fayez A.
    Nephrol Ther; 2017 May 18; 13(3):176-182. PubMed ID: 28161266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.